Open AccessDexamethasone Treatment after the First Week of Life for Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review
Author(s) -
Lex W. Doyle,
Richard A. Ehrenkranz,
Henry L. Halliday
Publication year - 2010
Publication title -
neonatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.399
H-Index - 84
eISSN - 1661-7819
pISSN - 1661-7800
DOI - 10.1159/000286212
Subject(s) - medicine , bronchopulmonary dysplasia , dexamethasone , pediatrics , randomized controlled trial , respiratory failure , intensive care medicine , surgery , gestational age , pregnancy , genetics , biology
Dexamethasone has powerful anti-inflammatory effects and has been used to treat established bronchopulmonary dysplasia (BPD), but it is uncertain whether the benefits outweigh the risks of treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom